Find verified Siponimod hemiadipate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Siponimod hemiadipate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Siponimod hemiadipate API.
Alternate Names: Siponimod Adipic Acid, Hexanedioic acid, compd. with 1-[[4-[(1E)-1-[[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-ethylphenyl]methyl]-3-azetidinecarboxylic acid (1:2)
CAS No: 2982813-34-1
PubChem CID: 169490743
Mol Formula: C64H80F6N4O10
Mol Weight: 1179.3 g/mol
IUPAC Name: 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid;hexanedioic aci -Show More
API Description: Siponimod hemiadipate is used as a medication primarily for the treatment of multiple sclerosis (MS), specifically secondary progressive MS (SPMS). It is a selective sphingosine-1-phosphate (S1P) receptor modulator that works by reducing the activity of immune cells that can damage the nervous system. The "hemiadipate" refers to a specific salt form that helps stabilize the drug for formulation but does not alter its therapeutic action. This compound helps delay disability progression and reduces the frequency of relapses in MS patients.
